Markets wobble on second-wave fears
Speculation about a new lockdown in Britain saw the FTSE 100 slide 3.4% on Monday, its worst one-day loss since June.

The eyes of global investors were trained on London this week, but not for good reasons. Speculation about a new lockdown in Britain saw the FTSE 100 slide 3.4% on Monday, its worst one-day loss since June. The drop wiped £52bn off the value of British companies. Concern about a second wave of the pandemic in Spain and France also hit European bourses, with Germany’s Dax falling 4.6% on Monday. The FTSE remained volatile the following day but finished higher as Boris Johnson announced milder measures than many had feared.
Markets were already feeling woozy before this week’s new pandemic restrictions, says Rupert Thompson of wealth manager Kingswood. Global equities ended last week down 4.5% from their early September highs. “Central banks have now spent most of their ammunition,” but politicians are reluctant to provide further fiscal stimulus – in the UK, debate continues about extending furlough schemes beyond October. This week’s turmoil was a reminder that Covid-19 can still rattle investors.
And deservedly so – the new restrictions carry a significant economic cost, says Paul Dales of Capital Economics. We forecast that if this week’s new measures continue for several months then the recovery will be delayed, with the British economy unable to regain “its pre-crisis level until the second half of 2022”. If a two-week “circuit-breaking” lockdown is brought in at some point then GDP will take an immediate 5% hit. That would push back a full recovery until 2023, a year later than if there are no more restrictions.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It’s Britain’s fault!
For Wall Street traders, Monday brought back nasty memories of the crashes in March, say Ben Eisen and Anna Isaac in The Wall Street Journal. A 500-point fall in the Dow Jones index was accompanied by declines in oil and gold prices, a cross-asset washout that sparked “anxiety” about “further turbulence” to come.
Larry Kudlow, Donald Trump’s economic adviser, pointed the finger at Britain, telling a reporter that the market turmoil was “coming out of London” because of “worries that Britain might shut down”. But the US has its own headaches (including the upcoming election) and September is often the start of a “treacherous season”for markets, says Randall Forsyth in Barron’s. From Black Wednesday to Lehman Brothers going bankrupt, the month has a nasty habit of serving up the end-of-summer blues.
Long-suffering British investors have become accustomed to market whiplash. The FTSE All-Share has been “an absolute hound” in recent years, as Russ Mould of AJ Bell notes. Since the Brexit vote in 2016 it has underperformed all other major investment regions on a total returns basis. Even Latin America – where Brazilian turmoil has mingled with an Argentine debt default – has done better. The crucial problem is the FTSE’s heavy exposure to out-of-favour energy and finance stocks. That makes the market a value play by default. British shares are unlikely to shine until the world economy manages to stage a “strong, inflationary recovery”.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Bargain Britain boasts both value and momentum
Interview Ian Lance, manager of the Temple Bar Investment Trust, tells Andrew Van Sickle that the outlook for UK stocks has improved and healthy long-term returns are in prospect
By Andrew Van Sickle
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine